Search

Author/Creator Amin, Salma

1. Anti‐PD‐1/PD‐L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer. Issue 9 (24th January 2019)

Authors:
Gunda, Viswanath; Gigliotti, Benjamin; Ashry, Tameem; Ndishabandi, Dorothy; McCarthy, Michael; Zhou, Zhiheng; Amin, Salma; Lee, Kyu Eun; Stork, Tabea; Wirth, Lori; Freeman, Gordon J.; Alessandrini, Alessandro; Parangi, Sareh
Journal:
International journal of cancer
Issue:
Volume 144:Issue 9(2019)
Page Start:
2266
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer. Issue 10 (13th November 2018)

Authors:
Gunda, Viswanath; Gigliotti, Benjamin; Ndishabandi, Dorothy; Ashry, Tameem; McCarthy, Michael; Zhou, Zhiheng; Amin, Salma; Freeman, Gordon; Alessandrini, Alessandro; Parangi, Sareh
Journal:
British journal of cancer
Issue:
Volume 119:Issue 10(2018)
Page Start:
1223
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗